Nyrada

Neuroprotection Program


 
    NYR Completes Safety Studies Ahead of Phase I Clinical Trial  
 
    Brain Injury Program GLP Studies Further Update 6  
 
    Brain Injury Program GLP Studies Further Update 5  
 
    Brain Injury Program GLP Studies Further Update 4  
 
    Brain Injury Program GLP Studies Further Update No 3  
 
    Brain Injury Program GLP Studies Further Update  
 
    GLP Studies Update  
 
    NYR Signs Strategic Partnership with US Brain Injury Company  
 
    Nyrada Commences Walter Reed Traumatic Brain Injury Study  
 
    Nyrada Commences Key Brain Injury Program Preclinical Study  
 
    Significant Neuroprotection in NYR Preclinical Brain Injury  
 
    Brain Injury Program Preclinical Development Update  
 
    Collaboration with Walter Reed and UNSW Extended to 2025  
 
    Brain Injury Program Update  
 
    Brain Injury Program Target Unveiled and Phase I Update  
 
    New Drug Offers Potential Oral Treatment for Concussion  
 
    Brain Injury Program Update and Pathway to Phase I  
 
    Improved Drug Candidate Selected for WRAIR Studies  
 
    NYR Secures Collaboration with Walter Reed and UNSW  
 
    Nyrada Brain Injury Drug Pharmacokinetic Study Results  
 
    Nyrada Brain Injury Data Published by Premier US Military Health Conference  
 
    Milestone Achieved in the Nyrada Brain Injury Program